Abzu specializes in AI-powered drug design, focusing on RNA therapeutics. Their unique approach combines explainable AI with data-driven methodologies to enhance drug discovery. This results in higher success rates and faster development timelines for pharmaceutical research and development.
Maximize success by testing only the best compounds; Reduce design time and project management overhead; Generate predictive models for siRNA activity; Design active and safe ASOs; Validate candidates through in-vitro screening.